These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 10997687)

  • 1. The missing link: a single unifying mechanism for diabetic complications.
    Nishikawa T; Edelstein D; Brownlee M
    Kidney Int Suppl; 2000 Sep; 77():S26-30. PubMed ID: 10997687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cellular and molecular mechanisms of diabetic complications.
    King GL; Brownlee M
    Endocrinol Metab Clin North Am; 1996 Jun; 25(2):255-70. PubMed ID: 8799700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of protein kinase C activation and the vascular complications of diabetes.
    Das Evcimen N; King GL
    Pharmacol Res; 2007 Jun; 55(6):498-510. PubMed ID: 17574431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperglycemia and the pathobiology of diabetic complications.
    Aronson D
    Adv Cardiol; 2008; 45():1-16. PubMed ID: 18230953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage.
    Nishikawa T; Edelstein D; Du XL; Yamagishi S; Matsumura T; Kaneda Y; Yorek MA; Beebe D; Oates PJ; Hammes HP; Giardino I; Brownlee M
    Nature; 2000 Apr; 404(6779):787-90. PubMed ID: 10783895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of mitochondrial ROS production on diabetic vascular complications.
    Nishikawa T; Kukidome D; Sonoda K; Fujisawa K; Matsuhisa T; Motoshima H; Matsumura T; Araki E
    Diabetes Res Clin Pract; 2007 Sep; 77 Suppl 1():S41-5. PubMed ID: 17452060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathophysiological mechanisms of diabetic angiopathy.
    Hammes HP
    J Diabetes Complications; 2003; 17(2 Suppl):16-9. PubMed ID: 12623164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Introduction of hyperglycemia and dyslipidemia in the pathogenesis of diabetic vascular complications.
    Xu Y; He Z; King GL
    Curr Diab Rep; 2005 Apr; 5(2):91-7. PubMed ID: 15794910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular understanding of hyperglycemia's adverse effects for diabetic complications.
    Sheetz MJ; King GL
    JAMA; 2002 Nov; 288(20):2579-88. PubMed ID: 12444865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperglycemia-associated alterations in cellular signaling and dysregulated mitochondrial bioenergetics in human metabolic disorders.
    Stefano GB; Challenger S; Kream RM
    Eur J Nutr; 2016 Dec; 55(8):2339-2345. PubMed ID: 27084094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Glycemic Indices (Hyperglycemia, Glucose Variability, and Hypoglycemia) with Oxidative Stress and Diabetic Complications.
    Papachristoforou E; Lambadiari V; Maratou E; Makrilakis K
    J Diabetes Res; 2020; 2020():7489795. PubMed ID: 33123598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycation as the glucose link to diabetic complications.
    Gugliucci A
    J Am Osteopath Assoc; 2000 Oct; 100(10):621-34. PubMed ID: 11105451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular complexities underlying the vascular complications of diabetes mellitus - A comprehensive review.
    Paul S; Ali A; Katare R
    J Diabetes Complications; 2020 Aug; 34(8):107613. PubMed ID: 32505477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperglycemia-induced oxidative stress and its role in diabetes mellitus related cardiovascular diseases.
    Fiorentino TV; Prioletta A; Zuo P; Folli F
    Curr Pharm Des; 2013; 19(32):5695-703. PubMed ID: 23448484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress.
    Rolo AP; Palmeira CM
    Toxicol Appl Pharmacol; 2006 Apr; 212(2):167-78. PubMed ID: 16490224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the sphingosine kinase-signaling pathway by high glucose mediates the proinflammatory phenotype of endothelial cells.
    Wang L; Xing XP; Holmes A; Wadham C; Gamble JR; Vadas MA; Xia P
    Circ Res; 2005 Oct; 97(9):891-9. PubMed ID: 16179586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of oxidative stress in the pathogenesis of type 2 diabetes mellitus micro- and macrovascular complications: avenues for a mechanistic-based therapeutic approach.
    Folli F; Corradi D; Fanti P; Davalli A; Paez A; Giaccari A; Perego C; Muscogiuri G
    Curr Diabetes Rev; 2011 Sep; 7(5):313-24. PubMed ID: 21838680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Investigation of a novel mechanism of diabetic complications: impacts of mitochondrial reactive oxygen species].
    Nishikawa T; Araki E
    Rinsho Byori; 2008 Aug; 56(8):712-9. PubMed ID: 18800628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High glucose-induced activation of protein kinase signaling pathways in vascular smooth muscle cells: a potential role in the pathogenesis of vascular dysfunction in diabetes (review).
    Srivastava AK
    Int J Mol Med; 2002 Jan; 9(1):85-9. PubMed ID: 11745003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Norman MacAlister Gregg Lecture. The pathogenesis of diabetic retinopathy.
    Larkins RG; Dunlop ME; Johnson EI
    Aust N Z J Ophthalmol; 1996 May; 24(2):97-104. PubMed ID: 9199738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.